AC Immune S.A.ACIUNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-7.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -28.10% |
| Q2 2025 | 31.92% |
| Q1 2025 | -12.93% |
| Q4 2024 | -95.54% |
| Q3 2024 | 3609.61% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | -99.97% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | -15.94% |
| Q3 2020 | 3.69% |
| Q2 2020 | -91.18% |
| Q1 2020 | 1328.02% |
| Q4 2019 | -97.43% |
| Q3 2019 | 2111.18% |
| Q2 2019 | -97.99% |
| Q1 2019 | 5248.68% |
| Q4 2018 | -39.13% |
| Q3 2018 | 13.66% |
| Q2 2018 | 39.09% |
| Q1 2018 | -91.12% |
| Q4 2017 | 1428.96% |
| Q3 2017 | 42.63% |
| Q2 2017 | -62.46% |
| Q1 2017 | 40.28% |
| Q4 2016 | 7.28% |
| Q3 2016 | -93.32% |
| Q2 2016 | 3999.38% |
| Q1 2016 | 54.60% |
| Q4 2015 | -98.71% |